These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 6954248)

  • 1. [Malignant melanoma. Clinicopathological analysis of 37 cases (author's transl)].
    Hwang WS; Ding YA; Lee WC; Leu FJ
    Taiwan Yi Xue Hui Za Zhi; 1982 Feb; 81(2):240-5. PubMed ID: 6954248
    [No Abstract]   [Full Text] [Related]  

  • 2. [Experience with adjuvant chemoimmunotherapy with DTIC and BCG in malignant melanoma (author's transl)].
    Pullmann H; Muth M
    Z Hautkr; 1982 Feb; 57(4):294-7. PubMed ID: 7080583
    [No Abstract]   [Full Text] [Related]  

  • 3. A randomized trial of adjuvant chemotherapy and immunotherapy in Stage I and Stage II cutaneous melanoma. An interim report.
    Sterchi JM; Wells HB; Case LD; Spurr CL; White DR; Richards F; Muss HB; Jackson DV; Stuart JJ; Cooper MR
    Cancer; 1985 Feb; 55(4):707-12. PubMed ID: 3967167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Unspecific immunological investigations in patients with malignant melanoma (author's transl)].
    Knopf B; Wätzig V
    Dermatol Monatsschr; 1982 Jan; 168(1):24-33. PubMed ID: 7044849
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical administration of BCG-immunotherapy in malignant melanoma (author's transl)].
    Wätzig V; Knopf B
    Arch Geschwulstforsch; 1979; 49(2):140-5. PubMed ID: 475550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cancer immunotherapy in dermatological view (author's transl)].
    Lübbe D; Gstöttner R
    Arch Geschwulstforsch; 1980; 50(2):182-5. PubMed ID: 7436703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Intranodular treatment with BCG of cutaneous and subcutaneous metastases of malignant melanoma (author's transl)].
    Balzarini GP; Cascinelli N; Fontana V; Veronesi U
    Tumori; 1974; 60(4):345-52. PubMed ID: 4439501
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of malignant melanoma (author's transl)].
    Civatte J; Jourdain JC
    MMW Munch Med Wochenschr; 1978 Mar; 120(12):403-6. PubMed ID: 306028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized trial of adjuvant therapy for "high risk" primary malignant melanoma.
    Wood WC; Cosimi AB; Carey RW; Kaufman SD
    Surgery; 1978 Jun; 83(6):677-81. PubMed ID: 644461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunoreactivity in patients with surgically removed melanoma in the course of BCG vaccination (author's transl)].
    Lochman I; Kyselá T; Machálek J; Lochmanová A; Beska F
    Cesk Dermatol; 1980; 55(6):372-7. PubMed ID: 7460040
    [No Abstract]   [Full Text] [Related]  

  • 11. Mature results of a phase III randomized trial of bacillus Calmette-Guerin (BCG) versus observation and BCG plus dacarbazine versus BCG in the adjuvant therapy of American Joint Committee on Cancer Stage I-III melanoma (E1673): a trial of the Eastern Oncology Group.
    Agarwala SS; Neuberg D; Park Y; Kirkwood JM
    Cancer; 2004 Apr; 100(8):1692-8. PubMed ID: 15073858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunotherapy with BCG as coadjuvant in the management of malignant melanomas].
    Céspedes de Gómez MM; Aguilar Velázquez G; Valles de Cortés Y
    Alergia; 1980 Apr; 27(2):69-86. PubMed ID: 7416444
    [No Abstract]   [Full Text] [Related]  

  • 13. [Malignant melanoma of the esophagus (author's transl)].
    Frank K; Bettendorf U; Reinhardt P
    Leber Magen Darm; 1981 Jan; 11(1):37-43. PubMed ID: 7219012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experience with BCG adjuvant immunotherapy in stage II malignant melanoma.
    Peter HH; Deutschmann EM; Schultheis W; Deicher H
    Dev Biol Stand; 1977 Apr 13-15; 38():537-40. PubMed ID: 344106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Melanoma therapy].
    Kleeberg UR
    Dtsch Med Wochenschr; 1976 Jun; 101(23):904-8. PubMed ID: 773624
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of intra-lesional injection of tuberculin-active protein on metastatic nodules of human malignant melanoma].
    Saida T
    Nihon Hifuka Gakkai Zasshi; 1982 Nov; 92(13):1399-414. PubMed ID: 6984865
    [No Abstract]   [Full Text] [Related]  

  • 17. [On malignant melanoma (author's transl)].
    Stein G
    Radiobiol Radiother (Berl); 1974; 15(4):475-9. PubMed ID: 4445496
    [No Abstract]   [Full Text] [Related]  

  • 18. [Diagnosis, pathology and therapy of malignant melanoma of the skin (author's transl)].
    Kerl H
    Wien Klin Wochenschr; 1976 Jun; 88(12):369-79. PubMed ID: 782045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignant melanoma.
    Lichtenfeld JL
    Med Clin North Am; 1977 Sep; 61(5):1013-25. PubMed ID: 330971
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunoprophylaxis of malignant melanoma with systemic BCG: study of strain, dose, and schedule.
    Gutterman JU; Mavligit G; McBride C; Frei E; Hersh EM
    Natl Cancer Inst Monogr; 1973 Dec; 39():205-12. PubMed ID: 4595319
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.